Novartis | NOVN - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 435.86B 8.73B 2026-08
Alcon AG USD 30.17B 6.88B 2026-08
Almirall EUR 2.76B 472.53M 2025-12
Amgen USD 209.65B 14.21B 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
Autolus Therapeutics Ltd USD 367.28M 0 2026-08
Bayer EUR 48.39B 834.21M 2026-08
Biogen USD 31.9B 5B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
Fresenius EUR 26.29B 3.78B 2026-08
Fresenius Medical Care EUR 12.42B 1.87B 2026-08
Genmab DKK 126.96B 109.86B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
GRIFOLS EUR 4.25B 1.16B 2026-08
Hikma Pharmaceutical USD 3.49B 1.14B 2026-08
J&J USD 611.36B 32.21B 2026-06
Lakefront Biotherapeutics EUR 1.61B 115.98M 2026-08
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 62.37B 43.39B 2026-08
Merck USD 324.18B 6.81B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Novo Nordisk A/S DKK 1.03T 373.76B 2026-08
Orion EUR 10.15B 316M 2026-06
Pfizer USD 153.17B 14.73B 2026-08
Philips EUR 23.09B 615.44M 2026-06
Recordati EUR 10.65B 209.88M 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
UCB EUR 46.41B 13.94B 2025-12